0 followers
MIRA1a is being developed as the first prescription drug to target the CB1 and CB2 receptors for chronic pain and anxiety without the impurities of marijuana or its side effects, such as increased appetite and paranoia.
This company has no teams yet
Anthropic
107 followers
Edged
1 follower
Thrive Capital
26 followers
Texas Christian University
16 followers
Menlo Ventures
11 followers
Malala Fund
5 followers
Girl Scouts of Southern Illinois Advancement
5 followers
Knoetic
4 followers
Core Spaces
4 followers
Magic Software Enterprises
3 followers
HistoSonics
3 followers
Explore companies